Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page displays the clinical-trial record for Tempol in COVID-19 patients, including its terminated status, study design, eligibility criteria, locations, and outcome measures.
    Difference
    52%
    Check dated 2026-11-08T17:10:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision indicator changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T17:21:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T18:21:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:36:30.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:31:33.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, indicating a new site revision. This update does not modify the study data or user-facing content.
    Difference
    18%
    Check dated 2026-09-20T20:45:49.000Z thumbnail image

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.